Introduction
Recombinant Human MAT1A Protein, also known as Methionine adenosyltransferase 1A, is a recombinant protein that plays a crucial role in the metabolism of methionine. This protein is produced through genetic engineering techniques and has various applications in the fields of biotechnology, medicine, and research.
Structure of Recombinant Human MAT1A Protein
Recombinant Human MAT1A Protein is a homotetrameric enzyme, meaning it is composed of four identical subunits. Each subunit has a molecular weight of approximately 39 kDa and consists of 395 amino acids. The primary structure of this protein has been well-studied and is highly conserved among different species.
The crystal structure of Recombinant Human MAT1A Protein has been determined, revealing its three-dimensional organization. The protein has a characteristic alpha/beta-barrel fold, with the active site located at the interface of two subunits. The active site contains a binding pocket for the substrates methionine and adenosine triphosphate (ATP).
Activity of Recombinant Human MAT1A Protein
Recombinant Human MAT1A Protein catalyzes the transfer of an adenosyl group from ATP to methionine, producing S-adenosylmethionine (SAM). SAM is a crucial molecule involved in various biochemical reactions, including methylation of DNA, RNA, proteins, and lipids. This process is essential for the proper functioning of cells and is particularly important for liver function.
The activity of Recombinant Human MAT1A Protein is regulated by various factors, including the levels of its substrates, products, and allosteric effectors. The enzyme is also subject to post-translational modifications, such as phosphorylation, which can affect its activity.
Applications of Recombinant Human MAT1A Protein
Recombinant Human MAT1A Protein has numerous applications in biotechnology, medicine, and research. Its primary use is in the production of SAM, which is a valuable compound in the pharmaceutical industry. SAM is used as a dietary supplement for its potential health benefits, such as improving liver function and treating depression.
In the field of biotechnology, Recombinant Human MAT1A Protein is used for the production of SAM-dependent enzymes, such as DNA methyltransferases, which are essential for epigenetic modifications. This protein is also used in the production of SAM-dependent antibiotics, such as erythromycin.
In medicine, Recombinant Human MAT1A Protein has potential therapeutic applications for various diseases, including liver diseases, cancer, and neurological disorders. It has been shown to improve liver function in patients with liver cirrhosis and prevent liver damage in patients undergoing chemotherapy. Additionally, studies have shown that this protein may have neuroprotective effects, making it a potential treatment for neurodegenerative diseases.
In research, Recombinant Human MAT1A Protein is used as a tool for studying the role of SAM in various biochemical processes. It is also used in the development of new drugs targeting SAM-dependent enzymes and in the investigation of potential therapeutic applications of SAM.
Conclusion
In conclusion, Recombinant Human MAT1A Protein is a vital enzyme with a well-characterized structure and activity. Its production through genetic engineering techniques has opened up numerous applications in biotechnology, medicine, and research. As our understanding of the role of SAM in various biochemical processes continues to grow, the potential uses of this protein will likely expand, making it an essential tool in the scientific community.
There are no reviews yet.